Login
Companies $RPID
$0.74 -$0.00 (0.2%) After hours
RAPID MICRO BIOSYSTEMS, INC. logo

RAPID MICRO BIOSYSTEMS, INC.

Compare classes
rapidmicrobio.com

What Do They Do?

Sells automated microbial-quality testing systems, consumables and related services to pharmaceutical manufacturers producing biologics, vaccines, cell and gene therapies, and sterile injectables.

How Do They Make Money?

Customers buy systems, software and consumables; payment is typically due 30 to 90 days after shipment or delivery. Service revenue comes from validation, installation and field work, plus maintenance contracts, with those services delivered at milestones or over the contract term.

revenue
SegmentShareRevenue
Product
Sold outright

70%
FY2022: 65%
Service
30%
FY2022: 35%

Who Are Their Customers?

Pharmaceutical manufacturers buy directly from the company’s sales teams in North America, Europe and Asia-Pacific, while distributors support some territories. MilliporeSigma has co-exclusive rights to sell systems and consumables for industrial quality-control uses.

Do Revenues Turn Into Profits?

No. It lost $47.1M in FY2025.

Operating income, FY2025
−141% of revenue
▲ +5% (Loss) vs FY2024 (−$49.9M, −178%)
Net income, FY2025
−140% of revenue
▼ 0% (Loss) vs FY2024 (−$46.9M, −167%)
Free cash flow, FY2025
−95% of revenue
▲ +30% (Loss) vs FY2024 (−$45.5M, −162%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
Revenue
▲ +11%
vs $7.3M in Q2 FY2025
Net income
▼ −9% (Loss)
vs −$11.9M in Q2 FY2025
Product share of revenue vs 66.1% in Q2 FY2025

Growing. Revenue grew 45% in 4 years, from $23.2M in FY2021 to $33.6M in FY2025, about 10% a year.

Broader sales channels The older report describes direct sales in North America and Europe; the latest report also describes direct sales in Asia-Pacific and distributors supporting certain territories.

Industrial quality-control markets The older report describes the platform for pharmaceutical manufacturing. The latest report adds a co-exclusive distribution arrangement covering industrial quality control in medical devices, personal care, cosmetics, and food and beverage.

Revenue over time
Product Service Non-Commercial Revenue
$50M$25M$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support